View in EDS

Trough dabrafenib plasma concentrations can predict occurrence of adverse events requiring dose reduction in metastatic melanoma.

Saved in:
Bibliographic Details
Title: Trough dabrafenib plasma concentrations can predict occurrence of adverse events requiring dose reduction in metastatic melanoma.
Authors: Rousset M; Département de Pharmacologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France; Univ. Bordeaux INSERM, Bordeaux Population Health Research Center, team PHARMACOEPIDEMIOLOGY, UMR 1219, F-33000 Bordeaux, France. Electronic address: marine.rousset@u-bordeaux.fr., Dutriaux C; Département de Dermatologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France., Bosco-Lévy P; Département de Pharmacologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France; Univ. Bordeaux INSERM, Bordeaux Population Health Research Center, team PHARMACOEPIDEMIOLOGY, UMR 1219, F-33000 Bordeaux, France., Prey S; Département de Dermatologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France., Pham-Ledard A; Département de Dermatologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France; EA2406 Histology and Molecular Pathology of Tumors, University of Bordeaux, F-33000, France., Dousset L; Département de Dermatologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France., Gérard E; Département de Dermatologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France., Bouchet S; Département de Pharmacologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France; Univ. Bordeaux INSERM, Bordeaux Population Health Research Center, team PHARMACOEPIDEMIOLOGY, UMR 1219, F-33000 Bordeaux, France., Canal-Raffin M; Département de Pharmacologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France; Univ. Bordeaux INSERM, Bordeaux Population Health Research Center, team Cancer-environnement-EPICENE, UMR 1219, F-33000 Bordeaux, France., Titier K; Département de Pharmacologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France., Molimard M; Département de Pharmacologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France; Univ. Bordeaux INSERM, Bordeaux Population Health Research Center, team PHARMACOEPIDEMIOLOGY, UMR 1219, F-33000 Bordeaux, France. Electronic address: mathieu.molimard@u-bordeaux.fr.
Source: Clinica chimica acta; international journal of clinical chemistry [Clin Chim Acta] 2017 Sep; Vol. 472, pp. 26-29. Date of Electronic Publication: 2017 Jul 12.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 1302422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3492 (Electronic) Linking ISSN: 00098981 NLM ISO Abbreviation: Clin Chim Acta Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 28709799
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Trough dabrafenib plasma concentrations can predict occurrence of adverse events requiring dose reduction in metastatic melanoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Rousset+M%22">Rousset M</searchLink>; Département de Pharmacologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France; Univ. Bordeaux INSERM, Bordeaux Population Health Research Center, team PHARMACOEPIDEMIOLOGY, UMR 1219, F-33000 Bordeaux, France. Electronic address: marine.rousset@u-bordeaux.fr.<br /><searchLink fieldCode="AU" term="%22Dutriaux+C%22">Dutriaux C</searchLink>; Département de Dermatologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Bosco-Lévy+P%22">Bosco-Lévy P</searchLink>; Département de Pharmacologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France; Univ. Bordeaux INSERM, Bordeaux Population Health Research Center, team PHARMACOEPIDEMIOLOGY, UMR 1219, F-33000 Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Prey+S%22">Prey S</searchLink>; Département de Dermatologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Pham-Ledard+A%22">Pham-Ledard A</searchLink>; Département de Dermatologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France; EA2406 Histology and Molecular Pathology of Tumors, University of Bordeaux, F-33000, France.<br /><searchLink fieldCode="AU" term="%22Dousset+L%22">Dousset L</searchLink>; Département de Dermatologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Gérard+E%22">Gérard E</searchLink>; Département de Dermatologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Bouchet+S%22">Bouchet S</searchLink>; Département de Pharmacologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France; Univ. Bordeaux INSERM, Bordeaux Population Health Research Center, team PHARMACOEPIDEMIOLOGY, UMR 1219, F-33000 Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Canal-Raffin+M%22">Canal-Raffin M</searchLink>; Département de Pharmacologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France; Univ. Bordeaux INSERM, Bordeaux Population Health Research Center, team Cancer-environnement-EPICENE, UMR 1219, F-33000 Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Titier+K%22">Titier K</searchLink>; Département de Pharmacologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Molimard+M%22">Molimard M</searchLink>; Département de Pharmacologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France; Univ. Bordeaux INSERM, Bordeaux Population Health Research Center, team PHARMACOEPIDEMIOLOGY, UMR 1219, F-33000 Bordeaux, France. Electronic address: mathieu.molimard@u-bordeaux.fr.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%221302422%22">Clinica chimica acta; international journal of clinical chemistry</searchLink> [Clin Chim Acta] 2017 Sep; Vol. 472, pp. 26-29. <i>Date of Electronic Publication: </i>2017 Jul 12.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>1302422 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-3492 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200098981%22">00098981 </searchLink><i>NLM ISO Abbreviation: </i>Clin Chim Acta <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=28709799
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.cca.2017.07.012
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 26
    Titles:
      – TitleFull: Trough dabrafenib plasma concentrations can predict occurrence of adverse events requiring dose reduction in metastatic melanoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rousset M
      – PersonEntity:
          Name:
            NameFull: Dutriaux C
      – PersonEntity:
          Name:
            NameFull: Bosco-Lévy P
      – PersonEntity:
          Name:
            NameFull: Prey S
      – PersonEntity:
          Name:
            NameFull: Pham-Ledard A
      – PersonEntity:
          Name:
            NameFull: Dousset L
      – PersonEntity:
          Name:
            NameFull: Gérard E
      – PersonEntity:
          Name:
            NameFull: Bouchet S
      – PersonEntity:
          Name:
            NameFull: Canal-Raffin M
      – PersonEntity:
          Name:
            NameFull: Titier K
      – PersonEntity:
          Name:
            NameFull: Molimard M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2017 Sep
              Type: published
              Y: 2017
          Identifiers:
            – Type: issn-electronic
              Value: 1873-3492
          Numbering:
            – Type: volume
              Value: 472
          Titles:
            – TitleFull: Clinica chimica acta; international journal of clinical chemistry
              Type: main
ResultId 1